glp 1 agonist black box warning Popular weight-loss drugs shouldn't carry suicide warnings, FDA says – WJET/WFXP GLP-1 Agents Showed Broader Risks,

Supplementary searches were performed to identify overview of approved AOMs and background information

Although, at first glance, it is easy to overestimate the findings and assume they apply to everyone, this studys participants were a very specific group: older adults with type 2 diabetes

[DOI] [PMC free article] [PubMed] [Google Scholar] 63.Glucagon-like peptide-1 modulates cholesterol homeostasis by suppressing the miR-19b-induced downregulation of ABCA1

LEADER, liraglutide effect and action in diabetes: evaluation of cardiovascular outcome resultsa long-term evaluation

Endogenously, GLP-1 is secreted by intestinal L cells in response to food, and has multiple roles: enhancing insulin secretion (in a glucose-dependent way), reducing glucagon secretion, slowing gastric emptying, increasing feelings of fullness/satiety, and improving glucose disposal in peripheral tissues